Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression

American Journal of Clinical Nutrition

Volumn 95, Issue 2, 2012, Pages 420-427

  Chiu, Chih Chiang ^a,h   Frangou, Sophia ^b   Chang, Ching Jui ^d   Chiu, Wei Che ^d   Liu, Hsing Cheng ^a   Sun, I Wen ^e   Liu, Shen Ing ^e   Lu, Mong Liang ^f,h   Chen, Chun Hsin ^f,h   Huang, Shih Yi ^g   Dewey, Michael E ^c   Stewart, Robert ^c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Section of Epidemiology   (United Kingdom)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; LINOLEIC ACID; LINOLENIC ACID; MYRISTIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; STEARIC ACID;

AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; COGNITION; CONVALESCENCE; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EDUCATION; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; RECURRENT DISEASE; STRUCTURED QUESTIONNAIRE;

AGED; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EDUCATIONAL STATUS; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NUTRITIONAL STATUS; QUESTIONNAIRES; RECURRENCE; RISK FACTORS;

EID: 84863078139     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.015784     Document Type: Article

References (55)

1. Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, Reynolds CF III. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000;157:1949-54.
2. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000;46:219-27. (Pubitemid 30422228)
3. Lin PY, Huang SY, Su KP. A Meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010;15:140-7.
4. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91:757-70.
5. Samieri C, Feart C, Letenneur L, Dartigues JF, Peres K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008;88:714-21.
6. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 2003;77:803-8.
7. Kröger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr 2009;90:184-92.
8. Devore EE, Grodstein F, van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009;90:170-6.
9. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000;35:1305-12. (Pubitemid 32064179)
10. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007;85:1103-11. (Pubitemid 46557928)
11. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002;23:843-53. (Pubitemid 35217710)
12. Samieri C, Feart C, Proust-Lima C, Peuchant E, Dartigues JF, Amieva H, Barberger-Gateau P. Omega-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression. Neurobiol Aging 2010; 32:e13-22.
13. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997;38:2012-22. (Pubitemid 27468010)
14. First MB, Gibbon M, Spitzer RL. Structured clinical interview for DSM-IV axis I disorders SCID I: Clinical version, administration booklet. Washington, DC: American Psychiatric Press, 1997.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
16. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000;57:285-90. (Pubitemid 30140438)
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Chen CH, Chen WJ, Cheng AT. New approach to the validity of the alcohol use disorders identification test: stratum-specific likelihood ratios analysis. Alcohol Clin Exp Res 2005;29:602-8. (Pubitemid 40547863)
19. Wechsler D. Wechsler Adult Intelligence Scale-III. San Antonio, TX: The Psychological Corporation, 1997.
20. Wechsler D. The Wechsler Memory Scale. San Antonio, TX: Harcourt Brace: The Psychological Corporation, 1997.
21. D'Elia LF. Color Trail Test: psychological manual. Lutz, FL: Psychological Assessment Resources, Inc, 1994.
22. Tsai SL, Chiu HY. Constructing occupational scales for Taiwan. In: Althauser R, Wallace M, eds. Research in social stratification and mobility: a research annual. London, United Kingdom: JAI Press, Inc, 1991:229-53.
23. Chiu CC, Huang SY, Su KP, Lu ML, Huang MC, Chen CC, Shen WW. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 2003;13:99-103. (Pubitemid 36313283)
24. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997;43:1657-9.
25. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 2002;325:932-3. (Pubitemid 35265208)
26. Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005;65:1409-14. (Pubitemid 41552771)
27. Fekete K, Marosvolgyi T, Jakobik V, Decsi T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 2009;89(suppl):2070S-84S.
28. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
29. Dullemeijer C, Durga J, Brouwer IA, van de Rest O, Kok FJ, Brummer RJ, van Boxtel MP, Verhoef P. n-3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 2007;86:1479-85. (Pubitemid 350126254)
30. Rapp MA, Dahlman K, Sano M, Grossman HT, Haroutunian V, Gorman JM. Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry 2005;162:691-8. (Pubitemid 40489130)
31. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF III, Becker JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 2002;159:1424-7. (Pubitemid 34832728)
32. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003;100:1387-92. (Pubitemid 36184011)
33. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43. (Pubitemid 29270138)
34. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13. (Pubitemid 26144221)
35. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-24. (Pubitemid 44188484)
36. Cole GM, Frautschy SA. DHA may prevent age-related dementia. J Nutr 2010;140:869-74.
37. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005;135:549-55. (Pubitemid 40365217)
38. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L, LaFerla FM. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007;27:4385-95. (Pubitemid 46640724)
39. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC. n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008;87:449-54. (Pubitemid 351226084)
40. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007;62:1120-6. (Pubitemid 47599423)
41. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994;1213:277-88. (Pubitemid 24262911)
42. Lucas M, Mirzaei F, O'Reilly EJ, Pan A, Willett WC, Kawachi I, Koenen K, Ascherio A. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr 2011;93:1337-43.
43. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 2004;8:163-74. (Pubitemid 38678591)
44. Delion S, Chalon S, Herault J, Guilloteau D, Besnard JC, Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 1994;124:2466-76.
45. Blondeau N, Nguemeni C, Debruyne DN, Piens M, Wu X, Pan H, Hu X, Gandin C, Lipsky RH, Plumier JC, et al. Subchronic alpha- linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 2009;34:2548-59.
46. Nguemeni C, Delplanque B, Rovere C, Simon-Rousseau N, Gandin C, Agnani G, Nahon JL, Heurteaux C, Blondeau N. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 2010;61:226-33.
47. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806-11. (Pubitemid 38886573)
48. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011;24:519-25.
49. Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N YAcad Sci 2010;1207:155-62.
50. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF III, DeKosky ST, Becker JT. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008;10:345-57.
51. Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H, Chamari M, Djazayery A. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res 2010;178:112-5.
52. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998;43:705-12. (Pubitemid 28255198)
53. Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM, Epstein AA, Wilkins CH, Snyder AZ, Couture L, Schechtman K, et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry 2008;165:524-32. (Pubitemid 351694296)
54. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009;54:585-94.
55. Vercambre MN, Boutron-Ruault MC, Ritchie K, Clavel-Chapelon F, Berr C. Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women. Br J Nutr 2009;102:419-27.